Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy

Table 5 Relationship between percentage and absolute counting methodologies of tumor-infiltrating-lymphocyte subpopulations

Population of lymphocytes	n	rho2	P-value	P corrected value3
Pre-NAC
CD3	27	0.7182	< 0.001	< 0.0041
CD4	17	0.5071	0.0378	0.1512
CD8	27	0.6064	0.0008	0.00321
FOXP3	26	0.7192	< 0.001	< 0.0041
Post-NAC
CD3	55	0.7733	< 0.001	< 0.0041
CD4	30	0.6129	0.0003	0.00121
CD8	55	0.7338	< 0.001	< 0.0041
FOXP3	47	0.5387	0.0001	0.00041

¹P < 0.05;

²Spearman correlation coefficient test;

³Bonferroni correction. NAC: Neoadjuvant-chemotherapy.